|
| Tuesday, 4 April 2017, 08:56 HKT/SGT | |
| |  | |
Source: Eisai | |
|
|
|
TOKYO, Apr 4, 2017 - (JCN Newswire) - Eisai Co., Ltd. has announced that the smell identification test "UPSIT Series" will be launched today for sale to health insurance pharmacies and local governments in Japan. The UPSIT Series was developed by Sensonics International. Eisai has obtained exclusive rights to market the test in Japan, and has modified it for the Japanese market.
The UPSIT Series' 4-Item Pocket Smell Test is a multiple-choice test comprised of four microencapsulated odorant strips attached to a thick sheet of paper. The scents are released by lightly scratching the strips with a cotton swab or other tool, after which the person taking the test must attempt to select the correct name of the scent from four options that are provided. In this way, smell identification ability can be determined in approximately 3 minutes.
The sense of smell is one of the important senses for detecting hazards in daily life, such as rotten food, poor hygiene, gas leakage, and fires. Olfactory function, which includes the ability to identify smells (identification) and to detect a faint smell (detection), is influenced by age, physical condition, memory, and psychological state. Persons are often unaware the changes in the ability to identify smells, subjectively. The UPSIT Series, which objectively measures smell identification ability, makes it possible to detect and track changes in physical condition and psychological state.
This test will most likely be used in counseling sessions, such as during health consultations or health promotion events held by health insurance pharmacies or local governments. Should the person taking the test make any mistakes, it may be recommended that they undertake a review of their lifestyle, including sleep, exercise, dietary and smoking habits, under the guidance of a pharmacist or other relevant person. Alternatively, a visit to an otolaryngologist or a primary care physician may be recommended. It is important to note that the UPSIT Series is not an alternative for proper medical examinations and diagnosis by qualified medical professionals.
Scents are made up of multiple chemical substances. The roof of the nasal cavity contains 5 million olfactory receptor cells, each of which reacts to certain chemical substances. These cells work in concert to transmit smell information to the brain. The transmitted information is then integrated with information stored in the brain, including learned information, making it possible to identify "a certain smell".
As one part of the hhc solutions business, Eisai has been engaged for many years in activities for "creating communities where senior citizens can live in peace of mind". In carrying out these activities, Eisai has identified real world needs and issues, also called "clinical questions". By providing solutions to these clinical questions, in cooperation with stakeholders including local governments, medical institutions and pharmacies, Eisai seeks to make further contributions to support health promotion and health management of senior citizens.
About smell identification test UPSIT Series
The UPSIT Series' 4-Item Pocket Smell Test is a multiple-choice test comprised of a four microencapsulated odorant strips attached to a thick sheet of perforated paper. The scents are released by lightly scratching the strips with a cotton swab or other tool, after which the person taking the test must attempt to select the correct scent name from four options. In this way, smell identification ability can be confirmed in approximately 3 minutes. Please note that UPSIT is not medicine or a medical device, and is not an alternative for proper medical examinations and diagnosis by qualified medical professionals. The UPSIT was developed by Richard L. Doty, professor and director the Smell and Taste Center within the Department of Otorhinolaryngology, University of Pennsylvania. Professor Doty also founded Sensonics. Inc. in 1982, and has markeded the UPSIT under the trade name Smell Identification Test worldwide since that time. Multiple products are being developed with different numbers and types of scents.
The Pocket Smell Test contains a set of four scents for the person being tested to identify, including cool scents (minty etc.), sweet scents (strawberry etc.) and unpleasant scents (gas etc.). There are two versions of the 4-Item Pocket Smell Test available, both of which make use of four different scents.
About Sensonics International
Sensonics International, whose headquarters are located in Haddon Heights, NJ, USA, was founded in 1982 and is the largest manufacturer and distributor of smell and taste tests in the world. In addition to marketing a range of smell and taste testing products, it provides industrial and medical consulting services, including the training of organoleptic panels for the food, flavor and fragrance industries, product evaluation, screening of smell function of workpalce employees, and a host of other chemosensation-related activities. Its tests have been administered to over a million people world wide and its flagship test, the UPSIT, has been translated into 30 different langauges.
About smells
Olfactory function, which includes the ability to identify smells (identification) and to detect a faint smell (detection), and detect is influenced by age, physical condition, memory, and psychological state. Since changes in olfactory ability are seldom reported as a subjective symptom, objective confirmation is neccessary. The roof of the nasal cavity is said to have 5 million olfactory cells. Each olfactory cell has one type of receptor, which binds with chemical substances of a matching affinity. A scent is made up of multiple chemical substances, and the bound receptors assemble this information, and transmit it to the brain. There, it is integrated with information stored in the brain, and identifed as "a certain smell". Olfactory disorders are divided into: Respiratory Dysosmia, where scents do not reach the olfactory cells, Olfactory Mucosa Dysosmia, where the olfactory cells and olfactory nerves are damaged, Combined Dysosmia, a combination of the aforementioned, and Central Dysosmia, where the olfactory center or surrounding pathways are damaged.
Contact:
Public Relations Department,
Eisai Co., Ltd.
+81-3-3817-5120
Topic: Press release summary
Source: Eisai
Sectors: BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| Eisai |
| June 2, 2025 16:46 HKT/SGT |
|
Eisai to Launch "Pariet S," the First Proton Pump Inhibitor RX-to-OTC in Japan |
| May 28, 2025 16:45 HKT/SGT |
|
New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China |
| May 21, 2025 14:00 HKT/SGT |
|
Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025 |
| May 16, 2025 16:21 HKT/SGT |
|
Eisai Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro |
| Apr 30, 2025 13:17 HKT/SGT |
|
Eisai Representative Corporate Officer and CEO Haruo Naito Awarded the Order of the Rising Sun, Gold and Silver Star |
| Apr 18, 2025 15:52 HKT/SGT |
|
Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union |
| Apr 1, 2025 12:15 HKT/SGT |
|
Eisai to Divest Rights for Pariet in China to Peak Pharma |
| Mar 25, 2025 16:28 HKT/SGT |
|
World's First Early Alzheimer's Disease Treatment Developed in Japan LEQEMBI Receives Prime Minister's Award at the 12th Technology Management and Innovation Awards |
| Mar 25, 2025 11:21 HKT/SGT |
|
Eisai Selected as a Nadeshiko Brand 2025 as a Listed Company Excelling in Promotion of Women in the Workplace |
| Mar 10, 2025 19:24 HKT/SGT |
|
Eisai Recognized as "2025 Kenko Investment for Health" for the First Time and Certified as "Outstanding Organization Of Kenko Investment for Health Program (White 500)" for the Sixth Time |
| More news >> |
 |
|
|
|
